An Emerging Role of mTOR in Lipid Biosynthesis

被引:509
作者
Laplante, Mathieu [1 ]
Sabatini, David M. [1 ,2 ,3 ]
机构
[1] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA
[2] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA
[3] MIT, Koch Ctr Integrat Canc Res, Cambridge, MA 02139 USA
关键词
ACTIVATED RECEPTOR-GAMMA; MAMMALIAN TARGET; ADIPOCYTE DIFFERENTIATION; ADIPOSE-TISSUE; SREBP ACTIVITY; RAPAMYCIN; INSULIN; ACID; ADIPOGENESIS; METABOLISM;
D O I
10.1016/j.cub.2009.09.058
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipid biosynthesis is essential for the maintenance of cellular homeostasis. The lipids produced by cells (glycerolipids, fatty acids, phospholipids, cholesterol, and sphingolipids) are used as an energy source/reserve, as building blocks for membrane biosynthesis, as precursor molecules for the synthesis of various cellular products, and as signaling molecules. Defects in lipid synthesis or processing contribute to the development of many diseases, including obesity, insulin resistance, type 2 diabetes, non-alcoholic fatty liver disease, and cancer. Studies published over the last few years have shown that the target of rapamycin (TOR), a conserved serine/threonine kinase with an important role in regulating cell growth, controls lipid biosynthesis through various mechanisms. Here, we review these findings and briefly discuss their potential relevance for human health and disease.
引用
收藏
页码:R1046 / R1052
页数:7
相关论文
共 48 条
  • [1] Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets
    Abu-Elheiga, L
    Oh, WK
    Kordari, P
    Wakil, SJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (18) : 10207 - 10212
  • [2] New Insights into mTOR Signaling: mTORC2 and Beyond
    Alessi, Dario R.
    Pearce, Laura R.
    Garcia-Martinez, Juan M.
    [J]. SCIENCE SIGNALING, 2009, 2 (67) : pe27
  • [3] Regulation of ceramide biosynthesis by TOR complex 2
    Aronova, Sofia
    Wedaman, Karen
    Aronov, Pavel A.
    Fontes, Kristin
    Ramos, Karmela
    Hammock, Bruce D.
    Powers, Ted
    [J]. CELL METABOLISM, 2008, 7 (02) : 148 - 158
  • [4] Rapamycin inhibits human adipocyte differentiation in primary culture
    Bell, A
    Grunder, L
    Sorisky, A
    [J]. OBESITY RESEARCH, 2000, 8 (03): : 249 - 254
  • [5] The mammalian target of rapamycin regulates lipid metabolism in primary cultures of rat hepatocytes
    Brown, Nicholas F.
    Stefanovic-Racic, Maja
    Sipula, Ian J.
    Perdomo, German
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (11): : 1500 - 1507
  • [6] Obesity and hepatocellular carcinoma
    Caldwell, SH
    Crespo, DM
    Kang, HS
    Al-Osaimi, AMS
    [J]. GASTROENTEROLOGY, 2004, 127 (05) : S97 - S103
  • [7] Regulation of adipocyte differentiation and insulin action with rapamycin
    Cho, HJ
    Park, J
    Lee, HW
    Lee, YS
    Kim, JB
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 321 (04) : 942 - 948
  • [8] mTOR complex 2 in adipose tissue negatively controls whole-body growth
    Cybulski, Nadine
    Polak, Pazit
    Auwerx, Johan
    Rueegg, Markus A.
    Hall, Michael N.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (24) : 9902 - 9907
  • [9] New insights into sphingolipid metabolism and function in budding yeast
    Dickson, Robert C.
    [J]. JOURNAL OF LIPID RESEARCH, 2008, 49 (05) : 909 - 921
  • [10] Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI [10.1172/JCI23621, 10.1172/JCI200523621]